PUBLISHED DATE : Feb 2023 | Pages : 269
Fill out your details & get your free sample
The Global HIV Rapid Test Kits Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
269 Pages
106 Tables
126 Charts
5 Regions
20 Countries
25 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 1.68 Billion |
| Market Size (2022) | USD 1.43 Billion |
| CAGR (2022-2028) | 2.70% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Technology, Sample Type, Distribution Channels, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Abbott, Bio-Rad Laboratories, BIOMÉRIEUX, Chembio Diagnostics, and OraSure Technologies |
The global HIV rapid test kits market size was valued at USD 1.437 billion in 2022 and is expected to reach USD 1.68 billion by 2028, growing at a CAGR of 2.70%. In the U.S., HIV testing is vital and integral to HIV prevention and management. The knowledge about HIV infection is increasing rapidly in the country, accelerating the high demand for HIV self-testing. In recent years, the significant patient population in the country has gone through routine medical checkups, which includes HIV test. It increases the knowledge about HIV testing and care in the country and propels the market growth.
Human Immunodeficiency Virus (HIV) is a viral infection that attacks the body's immune system and does not have effective care treatment across the world. It leads to acquired immunodeficiency syndrome (AIDS). Globally, more than 38.4 million people are living with HIV infection, among which Africa accounted for the higher patient population. HIV is one of the leading causes of death in the world. The Joint United Nations Programme on HIV/AIDS and WHO are two major health organizations working towards increasing awareness among people about HIV, HIV infection, and associated preventive measures. These two organizations aim to reduce around 90% HIV burden of the world by 2030. Based on that, several countries joined these initiatives to improve their national HIV status. HIV self-testing (HIVST) is one of the major strategies addressed by WHO and UNIAIDS to overcome the HIV burden. These steps lead to an increase in demand for HIVST that directly impact the HIV rapid test kits market.
In APAC, some countries do not have manufacturing facilities and largely depend on other countries to import the product. In Indonesia, there are no manufacturing companies for HIV rapid test kits. So, Indonesia imports HIV rapid test kits from India, China, Sweden, and other countries. Due to this, there is lower competition available for HIV rapid test kits market players. The fast-tracking HIV self-testing implementation and scale-up are one of the major priorities included by the WHO to reduce the infection rate in the region. Most APAC countries discussed starting HIVST pilot projects. These initiatives are expected to drive the demand for HIV rapid test kits and accelerate the market growth in the region.
Raise of Next-Generation HIV Test Technology
The rise of fourth-generation rapid test kits has become more popular in recent years. This technology is more accurate and reliable for screening the acute HIV presence in the sample. The 4th generation HIV test easily detects HIV in lesser time and more accurately than other generation technologies. Such factors allow individuals to get a cure sooner and potentially prevent the spread of infection to others. One of the leading HIV rapid test kit market players, OraSure technologies, got approval for a home test kit known as “OraQuick In-Home HIV Test,” which gives results in 20 to 40 minutes.
Increasing HIV Self-Testing Associated Government Policies
The UNAID and WHO are working together towards HIV prevention. Several strategic implementations are implemented worldwide to increase HIV self-testing (HIVST) and to understand the actual burden of HIV/AIDS globally. Eastern and Southern Africa, and Western and Central Europe & North America are the regions that implemented several HIVST policies that deliver HIV rapid test kits market growth opportunities. Due to the increasing acceptance of HIVST, the knowledge and awareness about HIV increased among the people, resulting in many people looking for easy HIV testing.
New Paradigm of Digital Support In HIV Self-Testing
The COVID-19 pandemic led to several service disruptions in the supply of HIV diagnoses and treatments, which led to falling short of the UNAIDS 2030 target. However, the COVID-19 pandemic accelerated the application of digital tools in health services. The incorporation of digital tools gave a new paradigm in HIV care management. The application of digital tools in HIV management is increasing that expected to fuel the HIV rapid test kits market. According to The Lancet research, the adoption and innovation of digital HIV self-testing tools have been increasing recently, and website-based innovations are becoming more popular.
Increasing Targeted Patient Population
Around 15,000,000 people acquired HIV in 2020. In 2022, more than 38 million people were expected to live with HIV. This further results in increasing HIV preventive measures, which include increasing the number of people undergoing HIV tests through self-test kits. In high-infection regions such as Africa, Europe, and Asian countries, the demand for HIV testing is increasing year by year, which drives the application rate of HIV rapid test kits and propels market growth.
Increasing Awareness about HIV Self-Testing
Most countries are making significant progress in reducing the HIV burden with UNAIDS and WHO. Globally, around 95% of people living with HIV are expected to be aware of their HIV status by 2025. Further, the increasing prevalence of HIV, the awareness among HIV-infected and non-infected people in developed and developing countries is increasing rapidly. In developed countries, HIV infection awareness increased through various government and health authorities’ programs working as support to improve knowledge about HIV self-testing solutions. The increasing access to HIV rapid test kits through health authorities and vendor activities and the acceptance of self-testing kits for HIV management are increasing simultaneously, fueling the HIV rapid test kits market growth.
INSIGHTS BY TECHNOLOGY
The global HIV rapid test kits market based on technology is segmented into lateral flow immunoassay and immunofixation. The lateral flow immunoassay segment accounted for a 78.25% market share in 2021. A higher number of HIV rapid test kit products are available and approved by various health authorities in the market and are developed by the lateral flow immunoassay technology. This technology delivers several advantaged and accurate results in HIV rapid testing. One of the major reasons for increasing preference towards the usage of HIV rapid test kits is their immediate results. The quicker results will help healthcare professionals to make treatment plans in the market. Quicker diagnosis of the disease will help the healthcare providers to safeguard the patients and to take enough preventive measures to reduce the spread of the disease in the market.
INSIGHTS BY SAMPLE TYPE
The blood sample type segment accounted for a higher 63.46% market share in the global HIV rapid test kits market and dominated the other segments. Blood sample-based HIV rapid test kits are highly recommended by medical professionals due to their potential to carry HIV antibodies in high proportion. In HIV testing, blood samples (plasma, serum, DBS) are highly preferred for HIV rapid testing. Blood samples carry higher concentrations of HIV antibodies than oral (saliva) samples. These sample-based HIV rapid testing found antibodies using a drop of blood from the fingertip. In addition to the individuals, healthcare settings also use HIV rapid test kits that drive blood sample segmental growth. In addition, HIV rapid test kits are distributed to patients through clinical laboratories, research centers, and community-based organizations.
INSIGHTS BY DISTRIBUTION CHANNELS
The offline segment dominates the distribution channels and accounts for a 66.70% global HIV rapid test kits market share. Offline sales channels included medical shops, pharmacies, hospitals, clinics, associated pharmacies, and pharma retailers. Offline sales channels are the first point of resource for HIV testing in LMICs. In most developing countries, people choose medical pharmacies as the first care point to buy HIV rapid test kits. Easy access and availability with the convenience of buyers are the major factors that drive major sales through offline channels. In low- and middle-income countries, drug shops are critical in healthcare provisions, where they are often the first point of care access for medical solutions. Drug shops are the best alternative to conventional facility-based HIV testing and counseling, and offline stores offer significant advantages in those regions for HIV rapid test kits. Consumers avoid a longer wait and potential clinical staff and associated charges.
North America dominates the global HIV rapid test kits market accounting for a 31.06% market share. The factors that propel the market growth in the region are the higher HIV prevalence and the increasing awareness among the key patient populations. The government support and funding for HIV management as preventive measures drive the region's significant market growth. More than 3.8 million people in North America are estimated for HIV in 2022. The awareness about HIV self-testing is significantly high in the US, while Canada is showing progressive growth for HIV self-testing.
The Europe HIV rapid test kits market was valued at USD 158.77 million in 2022. It is estimated that the rate and number of new diagnoses of HIV infection are continuously increasing in East Europe and are growing rapidly, though from a much lower base in Central Europe region. On another side, in Western Europe, the annual number of new diagnoses is stable but constantly increasing in transgender and other men who have sex with men (MSM) in most Western and Central European regions.
The global HIV rapid test kits market has many global, regional, and domestic players that offer a comprehensive product portfolio of HIV rapid test kits. Some global market players have acquired high industry penetration with a broader distribution network and business strategies. Also, some companies collaborate with WHO and UNAIDS to increase the increasing rate of HIV self-testing by supporting HIV rapid test kits. In 2022, WHO partnered with the Clinton Health Access Initiative (CHAI), Wondfo Biotech Company, and MedAccess. This partnership makes available HIV-self-test kits for only USD 1 in the public sector of LMICs. This is expected to increase the high industry competition among leading market players. The inorganic growth strategies of leading market players create entry barriers for many small and emerging players.
Abbott, Bio-Rad Laboratories, BIOMÉRIEUX, Chembio Diagnostics, and OraSure Technologies are the key companies in the global HIV rapid test kits market. The competitive landscape is different in different countries. In North America, the competition for HIV rapid test kits is moderate due to the stringent regulation and guidelines for HIV rapid test kits approval. The US FDA-approved and OTC HIV rapid test kits are available. In some European countries, healthcare facilities provide the free distribution of HIV self-test kits to people to reduce the spread of infections.
Frequently Asked Questions
How big is the HIV rapid test kits market?
The global HIV rapid test kits market size was valued at USD 1.43 billion in 2022 and is expected to reach USD 1.68 billion by 2028.
What is the growth rate of the HIV rapid test kits market?
The global HIV rapid test kits market share is growing at a CAGR of 2.70% from 2022-2028.
Which region holds the most significant global HIV rapid test kits market share?
North America dominates the global HIV rapid test kits market with a share of 31.06%. The region shows a higher dominance over the other regions in the market due to the higher acceptance of HIV rapid tests among people.
What are the growing trends in the HIV rapid test kits market?
Raising demand for next-generation HIV rapid test kits, increasing acceptance of HIV self-testing and associated government policies, and a new paradigm of digital support in HIV self-testing are the growing trends in the HIV rapid test kits market.
Which are the key companies in the global HIV rapid test kits market?
Abbott, Bio-Rad Laboratories, BIOMÉRIEUX, Chembio Diagnostics, and OraSure Technologies are the key companies in the global HIV rapid test kits market.
The HIV rapid test kits market is expected to grow at a CAGR of approximately 2.70% from 2022 to 2028.
The following factors are likely to contribute to the growth of the HIV rapid test kits market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the HIV rapid test kits market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation by Technology
Segmentation by Sample Type
Segmentation by Distribution Channels
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET BY TECHNOLOGY
4.3.2 MARKET BY SAMPLE TYPE
4.3.3 MARKET BY DISTRIBUTION CHANNELS
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 OVERVIEW
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 INTRODUCTION OF NEXT GENERATION HIV RAPID TEST KITS
9.2 INCREASE IN HIV SELF-TESTING BY GOVERNMENT BODIES
9.3 DIGITAL SUPPORT FOR HIV SELF-TESTING
10 MARKET GROWTH ENABLERS
10.1 INCREASING HIV PATIENT POPULATION
10.2 INCREASED RESOURCES AVAILABILITY AND FUNDING FOR HIV MANAGEMENT
10.3 INCREASED AWARENESS OF HIV SELF-TESTING
11 MARKET RESTRAINTS
11.1 INCREASING INCIDENCES OF FALSE NEGATIVES
11.2 LIMITATIONS & CHALLENGES ASSOCIATED WITH HIV TESTING
11.3 LOW ACCESSIBLITY & LACK OF AWARENESS FOR HIVST
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 INSIGHTS BY TECHNOLOGY
12.1.2 INSIGHTS BY SAMPLE TYPE
12.1.3 INSIGHTS BY DISTRIBUTION CHANNELS
12.1.4 INSIGHTS BY GEOGRAPHY
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 TECHNOLOGY
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 LATERAL FLOW IMMUNOASSAY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 IMMUNOFILTRATION
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 SAMPLE TYPE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BLOOD
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 ORAL FLUID
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 URINE
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 DISTRIBUTION CHANNEL
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 OFFLINE
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 ONLINE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 TECHNOLOGY
17.3.1 MARKET SIZE & FORECAST
17.4 SAMPLE TYPE
17.4.1 MARKET SIZE & FORECAST
17.5 DISTRIBUTION CHANNELS
17.5.1 MARKET SIZE & FORECAST
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 APAC
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 TECHNOLOGY
18.3.1 MARKET SIZE & FORECAST
18.4 SAMPLE TYPE
18.4.1 MARKET SIZE & FORECAST
18.5 DISTRIBUTION CHANNELS
18.5.1 MARKET SIZE & FORECAST
18.6 KEY COUNTRIES
18.6.1 CHINA: MARKET SIZE & FORECAST
18.6.2 INDIA: MARKET SIZE & FORECAST
18.6.3 INDONESIA: MARKET SIZE & FORECAST
18.6.4 THAILAND: MARKET SIZE & FORECAST
18.6.5 VIETNAM: MARKET SIZE & FORECAST
19 MIDDLE EAST & AFRICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 TECHNOLOGY
19.3.1 MARKET SIZE & FORECAST
19.4 SAMPLE TYPE
19.4.1 MARKET SIZE & FORECAST
19.5 DISTRIBUTION CHANNELS
19.5.1 MARKET SIZE & FORECAST
19.6 KEY COUNTRIES
19.6.1 SOUTH AFRICA: MARKET SIZE & FORECAST
19.6.2 MOZAMBIQUE: MARKET SIZE & FORECAST
19.6.3 KENYA: MARKET SIZE & FORECAST
19.6.4 NIGERIA: MARKET SIZE & FORECAST
19.6.5 TANZANIA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 TECHNOLOGY
20.3.1 MARKET SIZE & FORECAST
20.4 SAMPLE TYPE
20.4.1 MARKET SIZE & FORECAST
20.5 DISTRIBUTION CHANNELS
20.5.1 MARKET SIZE & FORECAST
20.6 KEY COUNTRIES
20.6.1 FRANCE: MARKET SIZE & FORECAST
20.6.2 ITALY: MARKET SIZE & FORECAST
20.6.3 UKRAINE: MARKET SIZE & FORECAST
20.6.4 PORTUGAL: MARKET SIZE & FORECAST
20.6.5 RUSSIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 TECHNOLOGY
21.3.1 MARKET SIZE & FORECAST
21.4 SAMPLE TYPE
21.4.1 MARKET SIZE & FORECAST
21.5 DISTRIBUTION CHANNELS
21.5.1 MARKET SIZE & FORECAST
21.6 KEY COUNTRIES
21.6.1 BRAZIL: MARKET SIZE & FORECAST
21.6.2 MEXICO: MARKET SIZE & FORECAST
21.6.3 COLOMBIA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 ABBOTT
22.2.2 BIO-RAD LABORATORIES
22.2.3 BIOMÉRIEUX
22.2.4 CHEMBIO DIAGNOSTICS
22.2.5 ORASURE TECHNOLOGIES
23 KEY COMPANY PROFILES
23.1 ABBOTT
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 BIO-RAD LABORATORIES
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 BIOMÉRIEUX
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 CHEMBIO DIAGNOSTICS
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 ORASURE TECHNOLOGIES
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 ATOMO DIAGNOSTICS
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 ACCUBIOTECH
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 BIOLYTICAL LABORATORIES
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 BIOSYNEX
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 CUPID LIMITED
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 HUMAN
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 INTEC
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 J. MITRA & CO
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 MERIL LIFE SCIENCES
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 MP BIOMEDICALS
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 MEDSOURCE OZONE BIOMEDICALS
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 NANJING SYNTHGENE MEDICAL TECHNOLOGY
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 PREMIER MEDICAL
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 SD BIOSENSOR
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 KHB (SHANGHAI KEHUA BIO-ENGINEERING)
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 TÜRKLAB A.S.
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 TRINITY BIOTECH
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 WANTAI BIOPHARMA
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 WONDFO
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY TECHNOLOGY
26.3 MARKET BY SAMPLE TYPE
26.4 MARKET BY DISTRIBUTION CHANNELS
26.5 TECHNOLOGY: MARKET BY GEOGRAPHY
26.5.1 LATERAL FLOW IMMUNOASSAY: MARKET BY GEOGRAPHY
26.5.2 IMMUNOFILTRATION: MARKET BY GEOGRAPHY
26.6 SAMPLE TYPE: MARKET BY GEOGRAPHY
26.6.1 BLOOD SAMPLE TYPE: MARKET BY GEOGRAPHY
26.6.2 ORAL FLUID SAMPLE TYPE: MARKET BY GEOGRAPHY
26.6.3 URINE SAMPLE TYPE: MARKET BY GEOGRAPHY
26.7 DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
26.7.1 OFFLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
26.7.2 ONLINE DISTRIBUTION CHANNELS: MARKET BY GEOGRAPHY
27 APPENDIX
27.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF THE GLOBAL HIV RAPID TEST KITS MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 EVOLUTION OF HIC RAPID TEST KITS
EXHIBIT 4 IMPACT OF INTRODUCTION OF NEXT GENERATION HIV RAPID TEST KITS
EXHIBIT 5 ADVANTAGES OF FOURTH-GENERATION HIV RAPID TEST KITS:
EXHIBIT 6 IMPACT OF INCREASE IN HIV SELF-TESTING BY GOVERNMENT BODIES
EXHIBIT 7 NATIONAL HIV SELF-TESTING POLICY & IMPLEMENTATION BY REGION (2020)
EXHIBIT 8 COUNTRIES IMPLEMENTING HIVST IN WORKPLACES
EXHIBIT 9 IMPACT OF DIGITAL SUPPORT FOR HIV SELF-TESTING
EXHIBIT 10 DIGITAL HIV SELF-TESTING INNOVATIONS 2021
EXHIBIT 11 IMPACT OF INCREASING HIV PATIENT POPULATION
EXHIBIT 12 GLOBAL DISTRIBUTION OF NEW HIV INFECTIONS BY POPULATION 2021
EXHIBIT 13 NUMBER OF HIV TESTS & TEST POSITIVITY RATE IN SUB-SAHARAN AFRICA REGION (2017–2021)
EXHIBIT 14 GLOBAL HIV INFECTION AND ASSOCIATED STATISTICS 2021
EXHIBIT 15 HIV PATIENT POPULATION BY REGION 2021 (MILLION)
EXHIBIT 16 IMPACT OF INCREASED RESOURCES AVAILABILITY AND FUNDING FOR HIV MANAGEMENT
EXHIBIT 17 AVAILABILITY OF RESOURCES FOR HIV MANAGEMENT IN LMICS 2010 TO 2021 ($ BILLION)
EXHIBIT 18 FUNDING PROPOSED BY SEVERAL AGENCIES IN THE US FOR HIV MANAGEMENT 2022–2023
EXHIBIT 19 IMPACT OF INCREASED AWARENESS OF HIV SELF-TESTING
EXHIBIT 20 ESTIMATED AND PROJECTED HIV SELF-TESTING REQUIREMENTS FOR LMICS FROM 2020 TO 2025 (MILLION)
EXHIBIT 21 IMPACT OF INCREASING INCIDENCES OF FALSE NEGATIVES
EXHIBIT 22 IMPACT OF LIMITATIONS & CHALLENGES ASSOCIATED WITH HIV TESTING
EXHIBIT 23 REASONS FOR SKIPPING OF HIV TESTS
EXHIBIT 24 IMPACT OF LOW ACCESSIBILITY & LACK OF AWARENESS FOR HIVST
EXHIBIT 25 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2020 & 2028
EXHIBIT 26 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2020 & 2028
EXHIBIT 27 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2020 & 2028
EXHIBIT 28 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2020 & 2028
EXHIBIT 29 GLOBAL HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 30 FIVE FORCES ANALYSIS 2022
EXHIBIT 31 INCREMENTAL GROWTH BY TECHNOLOGY 2022 & 2028
EXHIBIT 32 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028
EXHIBIT 33 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY: MARKET OVERVIEW
EXHIBIT 34 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
EXHIBIT 35 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 38 GLOBAL IMMUNO-FILTRATION HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL IMMUNOFILTRATION HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 40 INCREMENTAL GROWTH BY SAMPLE TYPE 2022 & 2028
EXHIBIT 41 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022-2028
EXHIBIT 42 GLOBAL HIV RAPID TEST KITS MARKET: SAMPLE TYPE OVERVIEW
EXHIBIT 43 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE: INCREMENTAL GROWTH
EXHIBIT 44 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE: ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL BLOOD SAMPLE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL BLOOD SAMPLE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 47 GLOBAL ORAL FLUID-BASED HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL ORAL FLUID-BASED HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 49 GLOBAL URINE SAMPLE-BASED HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 50 GLOBAL URINE SAMPLE-BASED HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 51 INCREMENTAL GROWTH BY DISTRIBUTION CHANNEL 2022 & 2028
EXHIBIT 52 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028
EXHIBIT 53 GLOBAL HIV RAPID TEST KITS MARKET: DISTRIBUTION CHANNELS OVERVIEW
EXHIBIT 54 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS: INCREMENTAL GROWTH
EXHIBIT 55 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS: ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL OFFLINE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL OFFLINE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 58 GLOBAL ONLINE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL ONLINE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 61 GLOBAL HIV RAPID TESTING MARKET BY GEOGRAPHY 2022–2028
EXHIBIT 62 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 63 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL HIV RAPID TEST KITS MARKET: GEOGRAPHY OVERVIEW
EXHIBIT 65 NORTH AMERICA HIV RAPID TEST KITS MARKET: KEY COUNTRIES
EXHIBIT 66 NORTH AMERICA HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 67 NORTH AMERICA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 69 US HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 70 PROGRESS TOWARD GLOBAL HIV MANAGEMENT TARGET IN CANADA2020–2025
EXHIBIT 71 CANADA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 72 APAC HIV RAPID TEST KITS MARKET: KEY COUNTRIES
EXHIBIT 73 APAC HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 74 APAC HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 75 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 76 CHINA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 77 INDIA KEY HIV STATISTICS 2021
EXHIBIT 78 INDIA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 79 TOTAL HIV CASES IN INDONESIA 2010-2021
EXHIBIT 80 INDONESIA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 81 THAILAND HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 82 VIETNAM: KEY FACTS ON HIV IN 2021
EXHIBIT 83 VIETNAM HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 84 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET: KEY COUNTRIES
EXHIBIT 85 MIDDLE EAST & AFRICA NATIONAL HIVST POLICIES & IMPLEMENTATION 2020 (REGION)
EXHIBIT 86 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 87 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 88 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 89 SOUTH AFRICA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 90 MOZAMBIQUE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 91 CHALLENGES IN KENYA PHARMACIES WITH DISTRIBUTION OF HIV SELF-TEST KITS
EXHIBIT 92 KENYA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 93 NIGERIA: HIV PREVALENCE 2021
EXHIBIT 94 NIGERIA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 95 HIVST CONFIRMED SPECIFIC VOLUME IN TANZANIA 2020
EXHIBIT 96 TANZANIA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 97 ESTIMATED NEW HIV INFECTIONS & NEW DIAGNOSIS IN WHO EUROPEAN REGION 2012 TO 2021
EXHIBIT 98 EUROPE HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 99 EUROPE HIV RAPID TEST KITS MARKET: KEY COUNTRIES
EXHIBIT 100 SPAIN HIV STATISTICS 2021
EXHIBIT 101 GERMANY: PEOPLE LIVING WITH HIV AND NEW HIV INFECTION CASES 2015 TO 2020
EXHIBIT 102 EUROPE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 103 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 104 FRANCE HIV PATIENT POPULATION STATISTICS IN 2021
EXHIBIT 105 FRANCE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 106 HIV PREVALENCE & ASSOCIATED STATISTICS IN ITALY 2021
EXHIBIT 107 ITALY HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 108 UKRAINE: PROGRESS TOWARD ACHIEVING UNAIDS GOALS (2017–2019)
EXHIBIT 109 UKRAINE HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 110 PORTUGAL HIV CASES FROM 2010 TO 2021
EXHIBIT 111 PORTUGAL HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 112 RUSSIA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 113 LATIN AMERICA HIV RAPID TEST KITS MARKET: INCREMENT GROWTH & ABSOLUTE GROWTH
EXHIBIT 114 LATIN AMERICA HIV RAPID TEST KITS MARKET: KEY COUNTRIES
EXHIBIT 115 LATIN AMERICA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 116 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 117 AWARENESS, ACCEPTABILITY, & WILLINGNESS OF HEALTHCARE PROFESSIONALS OFFERING HIVST IN BRAZIL 2019–2020
EXHIBIT 118 BRAZIL HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 119 MEXICO: HIV STATISTICS 2021
EXHIBIT 120 MEXICO HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 121 HIV & AIDS ESTIMATIONS IN COLOMBIA 2021
EXHIBIT 122 COLOMBIA HIV RAPID TEST KITS MARKET 2022–2028 ($ MILLION)
EXHIBIT 123 VENDORS OFFERING HIV RAPID TEST KITS: MARKET DOMINANCE ANALYSIS
EXHIBIT 124 VENDORS OFFERING HIV RAPID TEST KITS: CAPABILITIES AND EXPERTISE ASSESSMENT
EXHIBIT 125 ABBOTT ANNUAL REVENUE (2019–2021) ($ MILLION)
EXHIBIT 126 ORASURE TECHNOLOGIES ANNUAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 127 ORASURE TECHNOLOGIES HIV PORTFOLIO REVENUE 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2022
TABLE 3 SOME FOURTH GENERATION HIV RAPID TEST KITS
TABLE 4 FLUORESCENT CHROMATOGRAPHY TECHNOLOGY-BASED HIV RAPID TEST KITS
TABLE 5 SOME LEADING MARKET PLAYERS WITH LATERAL FLOW IMMUNOASSAY-BASED HIV RAPID TEST KITS
TABLE 6 LATERAL FLOW IMMUNOASSAY MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 7 LATERAL FLOW IMMUNOASSAY MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 8 IMMUNOFILTRATION TECHNOLOGY-BASED HIV RAPID TEST KITS
TABLE 9 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 10 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 11 BLOOD SAMPLE-BASED HIV RAPID TEST KITS & MANUFACTURING COMPANIES
TABLE 12 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 13 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 14 ORAL SAMPLE-BASED HIV RAPID TEST KITS
TABLE 15 ORAL FLUID-BASED HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022−2028 ($ MILLION)
TABLE 16 ORAL FLUID-BASED HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022−2028 (%)
TABLE 17 SOME URINE SAMPLE BASED HIV RAPID TEST KITS AVAILABLE IN GLOBAL MARKET
TABLE 18 URINE SAMPLE TYPE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 19 ORAL FLUID SAMPLE TYPE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 20 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 21 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 22 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 23 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 24 HIV BURDEN IN NORTH AMERICA 2021
TABLE 25 NORTH AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 26 NORTH AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 27 NORTH AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 ($ MILLION)
TABLE 28 NORTH AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 (%)
TABLE 29 NORTH AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 ($ MILLION)
TABLE 30 NORTH AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 (%)
TABLE 31 APAC HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 32 APAC HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 33 APAC HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 ($ MILLION)
TABLE 34 APAC HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 (%)
TABLE 35 APAC HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 ($ MILLION)
TABLE 36 APAC HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 (%)
TABLE 37 FUNDING FOR SUSTAINABLE HIV SERVICES FOR MOROCCO, TUNISIA, EGYPT, JORDAN, AND LEBANON
TABLE 38 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022−2028 ($ MILLION)
TABLE 39 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022−2028 (%)
TABLE 40 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022−2028 ($ MILLION)
TABLE 41 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022−2028 (%)
TABLE 42 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 ($ MILLION)
TABLE 43 MIDDLE EAST & AFRICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 (%)
TABLE 44 LIST OF LEADING EUROPEAN COUNTRIES WITH HIGHEST HIV CASES (2022)
TABLE 45 SOME HIV RAPID TEST KITS USED AS HOME HIV TEST KITS IN UK
TABLE 46 EUROPE HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 47 EUROPE HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 48 EUROPE HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 ($ MILLION)
TABLE 49 EUROPE HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 (%)
TABLE 50 EUROPE HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 ($ MILLION)
TABLE 51 EUROPE HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 (%)
TABLE 52 RUSSIA: REGULATION ON ENTRY, RESIDENCE, AND STAY FOR PEOPLE LIVING WITH HIV (2021)
TABLE 53 LATIN AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 54 LATIN AMERICA HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 (%)
TABLE 55 LATIN AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 ($ MILLION)
TABLE 56 LATIN AMERICA HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 (%)
TABLE 57 LATIN AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 ($ MILLION)
TABLE 58 LATIN AMERICA HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 (%)
TABLE 59 ABBOTT: MAJOR PRODUCT OFFERINGS
TABLE 60 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 61 BIOMÉRIEUX: MAJOR PRODUCT OFFERINGS
TABLE 62 CHEMBIO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 63 ORASURE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 64 ATOMO DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 65 ACCUBIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 66 BIOLYTICAL LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 67 BIOSYNEX: MAJOR PRODUCT OFFERINGS
TABLE 68 CUPID LIMITED: MAJOR PRODUCT OFFERINGS
TABLE 69 HUMAN: MAJOR PRODUCT OFFERINGS
TABLE 70 INTEC: MAJOR PRODUCT OFFERINGS
TABLE 71 J. MITRA & CO.: MAJOR PRODUCT OFFERINGS
TABLE 72 MERIL LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 73 MP BIOMEDICALS: MAJOR PRODUCT OFFERINGS
TABLE 74 MEDSOURCE OZONE BIOMEDICALS: MAJOR PRODUCT OFFERINGS
TABLE 75 NANJING SYNTHGENE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 76 PREMIER MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 77 SD BIOSENSOR: MAJOR PRODUCT OFFERINGS
TABLE 78 KHB: MAJOR PRODUCT OFFERINGS
TABLE 79 TÜRKLAB A.S.: MAJOR PRODUCT OFFERINGS
TABLE 80 TRINITY BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 81 WANTAI BIOPHARMA: MAJOR PRODUCT OFFERINGS
TABLE 82 WONDFO: MAJOR PRODUCT OFFERINGS
TABLE 83 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 84 GLOBAL HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 85 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 2022–2028 ($ MILLION)
TABLE 86 GLOBAL HIV RAPID TEST KITS MARKET BY TECHNOLOGY 202–2028 (%)
TABLE 87 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 ($ MILLION)
TABLE 88 GLOBAL HIV RAPID TEST KITS MARKET BY SAMPLE TYPE 2022–2028 (%)
TABLE 89 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 ($ MILLION)
TABLE 90 GLOBAL HIV RAPID TEST KITS MARKET BY DISTRIBUTION CHANNELS 2022–2028 (%)
TABLE 91 LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 92 LATERAL FLOW IMMUNOASSAY HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 93 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 94 IMMUNOFILTRATION HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 95 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 96 BLOOD SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 97 ORAL FLUID SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 98 ORAL FLUID SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 99 URINE SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 100 URINE SAMPLE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 101 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 102 OFFLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 103 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 ($ MILLION)
TABLE 104 ONLINE HIV RAPID TEST KITS MARKET BY GEOGRAPHY 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
